the staff costs didn’t go unnoticed. Almost $1M just last Q, $3M for FY. Last 5 years cumulative staff costs = $19M. Seems like you can enjoy years of comfortable and secure furlough free employment in this place... while investors bear the pain! Where do I find a job like this. Why does the company need a president US operations, a president in EU operations and a sales and marketing director? I’ll go with Gekkowolf’s D minus. Leadership has dodged taking tricky questions from market, last investor call was Feb 2019 which isn’t acceptable. Instead CEO sticks to friendly interviews with the likes of Dr Boreham, Finnews etc. Agree 4C tells us nothing new, nothing on final trial results, nothing about US LAPC strategy and FDA trial.
OSL Price at posting:
11.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)